Royalty fund

Last updated

A royalty fund (also known as royalty funding) is a category of private equity fund that specializes in purchasing consistent revenue streams deriving from the payment of royalties.[ citation needed ] Royalties are a usage-based payment from one individual or entity to another individual or entity, giving the right to use an asset, product, service or idea. [1]

Contents

One growing subset of this category is the healthcare royalty fund, in which a private equity fund manager purchases a royalty stream paid by a pharmaceutical company to a patent holder. The patent holder can be another company, an individual inventor, or some sort of institution, such as a research university. [2]


Structure of Royalty Investments

Royalty funds are a specific type of income trust, used for special-purpose finance, created to hold investments or cash flow in operating companies. These funds are not stocks or bonds but a form of investment fund. A royalty fund raises capital in order to purchase the right to a royalty of a product or service. However, unlike many other corporate entities, the profits derived from royalties are not taxed on a corporate level, but are distributed to shareholders in the form of a dividend, which is taxed on the personal income level. By doing so it avoids double taxation, enabling higher returns on dividends, thus making royalty funds an attractive investment. [3]

Royalty funds are structured in a number of ways. A fund can purchase a royalty or a percentage of a royalty from researchers at a university or a corporate entity for examples a biotech firm, therefore exchanging capital for ownership of the royalty. Alternatively, the fund can act as a private equity vehicle, extending debt or making loans, in exchange for a proportion of the royalty or securing other assets from the institution as collateral. Investments may go to fund a research project or cover costs of a research project. [3] Royalty funds invest in a range of business areas, including, mining, commodities, energy, entertainment, franchise, patents and IP, pharmaceuticals, and other trademark royalties.

An example would be a company making an investment into a pharmaceutical company through the acquisition of a healthcare product or service royalty. The operation of the pharmaceutical company continues, as usual, manufacturing and distribution of the products or services. But once the product has been sold a proportion of the profits will go to the fund that purchased the royalty (the amount or percentage will vary between companies based on the acquisition/investment terms). [4] [5]

Another example would be the purchase of royalties in the oil and gas industry, where the rights oil wells, oil mines or oil fields are owned by a royalty fund or also known as royalty trust. Other companies perform the operational aspect of extracting the minerals, paying a “royalty” in order to extract them. [6]

Examples

Intangible asset finance deals with the financing of intangible assets such as patents, trademarks, intellectual property, reputations, etc. In 2003, the intangible assets economy of the U.S. was estimated at $5 trillion.

History and Significant transactions

References

  1. "Definition Royalty". Investopedia. 2014. Retrieved 30 October 2014.
  2. Joseph Haas (2013). "DRI Capital To Pursue Phase III Assets With Some Of Its Third Royalty Fund". The Pink Sheet Daily.
  3. 1 2 "Royalty Income Trust". Investopedia. 2014. Retrieved 30 October 2014.
  4. Milburn, Robert (2014). "Funds that buy medical patents". barrons.com. Retrieved 30 October 2014.
  5. "Canada DRI Capital". PE HUB. 2013. Retrieved 30 October 2014.
  6. "Funds vs. Investment Trust". Morningstar. 2014. Retrieved 30 October 2014.
  7. "Royalty Pharma". Royalty Pharma. 2014. Retrieved 30 October 2014.
  8. "PDL BioPharma". PDL. 2014. Retrieved 30 October 2014.
  9. "Who's Who in Bowie Bonds". Projects.Exeter.ac.uk. 2007. Retrieved 30 October 2014.
  10. "Alder BioPharma Hits IPO". xconomy. 2000. Retrieved 30 October 2014.
  11. "Ocean Tomo" (PDF). Ocean Tomo. 2005. Retrieved 30 October 2014.
  12. Andrew Pollack for the New York Times. Nov 19, 2014 Deal by Cystic Fibrosis Foundation Raises Cash and Some Concern
  13. Lauren Arcuri Ware for the Robb Report. April 1, 2014 Venture Philanthropy: A New Driver for Research